Biotech highlight: SCYNEXIS (SCYX)Back to back announcements of good news.
This is a relatively new one for me in this space, but the news (in links below) of the NIH grant followed by the FDA approval of an additional indication will make following today's stock-price-action of interest!
www.scynexis.com
www.scynexis.com
(NOTE: NO